您的位置: 专家智库 > >

国家自然科学基金(81100160)

作品数:6 被引量:43H指数:3
相关作者:王曙霞陈敬洲薛浩邹玉宝王继征更多>>
相关机构:中国人民解放军总医院中国医学科学院中国协和医科大学更多>>
发文基金:国家自然科学基金国家科技支撑计划更多>>
相关领域:生物学医药卫生轻工技术与工程理学更多>>

文献类型

  • 6篇中文期刊文章

领域

  • 3篇生物学
  • 3篇医药卫生
  • 1篇轻工技术与工...
  • 1篇一般工业技术
  • 1篇理学

主题

  • 1篇动脉
  • 1篇动脉粥样硬化
  • 1篇心肌
  • 1篇心肌病
  • 1篇心肌肌球蛋白
  • 1篇型心
  • 1篇血栓
  • 1篇血栓诊断
  • 1篇血症
  • 1篇依折麦布
  • 1篇脂血症
  • 1篇中层厚度
  • 1篇上肢深静脉血...
  • 1篇深静脉
  • 1篇深静脉血栓
  • 1篇他汀
  • 1篇突变
  • 1篇球蛋白
  • 1篇重链
  • 1篇辛伐他汀

机构

  • 2篇中国人民解放...
  • 1篇中国医学科学...

作者

  • 2篇王曙霞
  • 1篇国希云
  • 1篇王虎
  • 1篇李丽娜
  • 1篇王继征
  • 1篇邹玉宝
  • 1篇陈德友
  • 1篇邓娴
  • 1篇薛浩
  • 1篇陈敬洲
  • 1篇路秀文

传媒

  • 2篇Chines...
  • 1篇中华老年心脑...
  • 1篇中国分子心脏...
  • 1篇Journa...
  • 1篇解放军医学院...

年份

  • 2篇2016
  • 1篇2014
  • 1篇2013
  • 2篇2012
6 条 记 录,以下是 1-6
排序方式:
Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese被引量:23
2012年
Background Left ventricular hypertrophy (LVH) and geometric abnormality are associated with morbidity and mortality of cardiovascular disease and stroke. Hypertension is the major cause of LVH. Yet the prevalence and other risk factors of LVH and geometric abnormality in Chinese hypertensive population are unknown. The objective of this study was to investigate the prevalence and risk factors of LVH and geometric abnormality in community-based Chinese hypertensive population. Methods The study was a community-based cross-sectional study, and comprised 4270 hypertension patients with integrated clinical and echocardiographic data. Left ventricular mass was measured by transthoracic echocardiography. LVH was diagnosed by using the criteria of over 49.2 g/m^2.7 for men and 46.7 g/m^2.7 for women. LV geometric patterns (normal, concentric remodeling, concentric or eccentric hypertrophy) were calculated according to LVH and relative wall thickness. Logistic regression model was used to determine the odds ratio (OR) and 95% confidence intervals (CI) of the risk factors of LVH. Results The prevalence of LVH was 42.7% in 4270 hypertensive patients, with 37.4% in males and 45.4% in females, respectively. The prevalence of concentric remodeling, concentric or eccentric hypertrophy was 24.7%, 20.2%, and 22.6%, respectively. In Logistic regression model, female (OR 1.3, 95%C/ 1.1-1.5, P 〈0.01), age (OR 1.02, 95%C/ 1.01-1.03, P 〈0.01), body mass index (OR 1.2, 95%C/1.15-1.20, P 〈0.01), systolic blood pressure (OR 1.02, 95%C/ 1.01-1.03, P 〈0.01 ), and serum triglyceride (OR 1.10, 95% CI 1.00-1.20, P 〈0.01 ) were risk factors of LVH. Female, age, body mass index, systolic blood pressure and serum triglyceride were also risk factors of left ventricular geometric abnormality. Conclusions The echocardiographic LVH is the major complication of patients with hypertension in rural area of China, especially for women. To effectively treat hypertension, weight loss and control of serum trig
WANG Shu-xiaXUE HaoZOU Yu-baoSUN KaiFU Chun-yanWANG HuHUI Ru-tai
Polymorphisms of angiotensin-converting enzyme 2 gene confer a risk to lone atrial fibrillation in Chinese male patients被引量:1
2013年
Background Growing epidemiologic evidence has indicated that genetics can predispose individuals to the occurrence of lone atrial fibrillation (AF). The angiotensin-converting enzyme 2 (ACE2) gene has been established to be associated with hypertension and left ventricular hypertrophy. The objective of our study was to investigate the association of ACE2 gene polymorphisms with lone AF. Methods A total of 265 consecutive lone AF patients and 289 healthy controls were successfully investigated. The polymorphisms rs2106809 and rs2285666 were genotyped by polymerase chain reaction (PCR) and direct sequencing. A Logistic regression model was used to determine the odds ratio (OR) and 95% confidence intervals (CO of variations of ACE2 for lone AF. Results The T allele of rs2106809 conferred an increased risk for lone AF (OR 1.24, 95% CI 1.01-1.52, P=0.03) in males after adjustment for conventional risk factors. SNP at rs2285666 in males was not significantly different between AF patients and controls. No association was found between the two polymorphisms in the female population with lone AF. After (36.3±4.5) months of follow-up, the end point data were obtained: death (cardiac and noncardiac), ischemic stroke, and heart failure. In the male subgroup, the associations between rs2106809 T male carriers and combined end points including ischemic stroke, heart failure, and death in our study were of significance (OR 3.6, 95% CI 1.0-13.1, P=-0.04). Conclusions The results indicate that polymorphism at ACE2 gene is associated with male lone AF in a Chinese Han population. Lone AF males who c.arrv the. rs2106809T alle.le, are. associate.d with adverse cardiac, e.ve.nts
WANG Shu-xia TAO Tao FU Zhi-qing XIE Xiang-zhu WANG Hao WANG Yu-tang
关键词:POLYMORPHISM
Long-term outcomes of high-risk elderly male patients with multivessel coronary disease: optimal medical therapy versus revascularization被引量:1
2016年
Background Many studies have indicated that medical therapy and percutaneous coronary intervention have similar effects in terms of the long-term prognosis of patients with stable coronary artery disease. This study investigated the effects of optimal medical therapy (OMT) and revascularization-plus-OMT in elderly patients with high-risk angina. Methods In this prospective non-randomized study, 241 consecutive high-risk elderly male patients (65-92 years of age) with angiographically confirmed multivessel disease were enrolled in the registry from January 2004 to April 2005. Of these, 98 patients underwent OMT and 143 underwent revascularization therapy plus OMT. Results After 6.5 years of follow-up, we found that the rate of long-term cardiac mortality was significantly higher in patients who under- went OMT than in those who underwent revascularization (6.5-year unadjusted mortality rate, 14.3% for OMT vs. 7.0% for revascularization patients; log-rank P = 0.04). However, the overall risks of major adverse cardiac cerebrovascular events (MACCE) were similar among all patients (6.5-year unadjusted mortality rate, 29.6% for OMT vs. 27.3% for revascularization patients; log-rank P = 0.67). Conclusions OMT was associated with an increase in cardiac death but a similar 6.5-year risk of MACCE compared with revascularization in high-risk elderly male patients with coronary multivessel disease.
Tao TAOHao WANGShu-Xia WANGYu-Tao GUOPing ZHUYu-Tang WANG
关键词:REVASCULARIZATION
β肌球蛋白重链及心脏型肌球蛋白结合蛋白C基因突变的肥厚型心肌病患者生存分析被引量:5
2012年
目的探讨携带β肌球蛋白重链(MYH7)及心脏型肌球蛋白结合蛋白C(MYBPC3)基因突变的肥厚型心肌病患者的6年生存情况。方法对采用测序方法确定的携带MYH7及MYBPC3基因突变的70例肥厚型心肌病患者进行前瞻性的随访。结果平均随访时间为(5.8±1.8)年,期间共有14例患者死亡,其中MYH7突变患者10例(32.1%/1000人年,95%CI为12.5~51.5),MYBPC3突变患者4例(35.2%/1000人年,95%CI为13.9~68.9),两者比较差异无统计学意义(P>0.05)。7例携带MYH7突变的患者发生猝死,基因突变的部位均位于MYH7基因的头部;而携带MYBPC3突变的患者均未发生猝死,两者比较差异有统计学意义(P<0.01)。结论携带MYH7基因突变的肥厚型心肌病患者发病年龄和死亡年龄均较早,猝死发生率高。携带位于MYH7基因头部突变的肥厚型心肌病患者较杆部突变患者的左心室最大室壁厚度更厚,猝死发生率高,更容易发生心力衰竭。对肥厚型心肌病患者进行基因检查十分必要。
王曙霞邹玉宝王虎王继征薛浩陈敬洲惠汝太
关键词:肌球蛋白重链心肌肌球蛋白基因型突变
上肢深静脉血栓诊断及治疗新进展被引量:11
2014年
近年来随着中心静脉导管的应用,上肢深静脉血栓的发生率逐年升高,肺栓塞以及栓塞后综合征等严重的并发症发生率也随之升高,因此正确诊断和治疗上肢深静脉血栓非常重要。本文对上肢静脉血栓的诊断、预防和治疗加以综述;但目前关于上肢静脉血栓资料非常有限,因此有些方面借鉴了下肢深静脉血栓的治疗指南。
赵晓宁王玉堂
关键词:上肢深静脉血栓
依折麦布联合辛伐他汀对高脂血症合并颈动脉粥样硬化的治疗作用被引量:2
2016年
目的观察依折麦布联合辛伐他汀对高脂血症合并动脉粥样硬化患者颈动脉内膜中层厚度(carotid arterial intima-media thickness,CIMT)的影响。方法采用随机、双盲研究,入选我院2013年6月至2014年8月门诊的高脂血症合并颈动脉粥样硬化患者,共108例,平均年龄67.4±9.3岁。将108例患者随机分为治疗组与对照组。所有患者均可正常饮食,继续原发病的常规治疗,停用其它降脂药物2周,以减少其它降脂药物对疗效判断的干扰,治疗组54例患者在辛伐他汀10 mg/d的基础上加用依折麦布5 mg/d,对照组54例患者使用辛伐他汀10 mg/d治疗4个月。均每日服药1次,于每晚入睡前或晚餐后3小时服用.4个月后以超声观察CIMT的变化,并采空腹静脉血,测定总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C),高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)。结果冶疗组与对照组的颈动脉内膜厚度及血脂水平均有明显下降,治疗组的颈动脉内膜中层厚度有下降更明显,从1.83±0.36mm下降至1.41±0.29mm,有统计学意义(p<0.01;且改善较对照组更明显(p<0.05),所有患者对依折麦布均能很好地耐受而且依从性较好,研究期间未发现药物相关严重不良反应。结论依折麦布联合辛伐他汀对高脂血症合并颈动脉粥样硬化的CIMT改善优于单用辛伐他汀组.并具有良好的安全性。
国希云李芳邓娴阳蒙蒙路秀文李丽娜王曙霞陈德友
关键词:依折麦布辛伐他汀动脉粥样硬化颈动脉内膜中层厚度
共1页<1>
聚类工具0